Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
5.59
+0.07 (1.27%)
At close: May 22, 2026, 4:00 PM EDT
5.48
-0.11 (-1.97%)
After-hours: May 22, 2026, 6:38 PM EDT

Harvard Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
252999302,3221,1402,901
Market Cap Growth
88.15%-67.84%-59.94%103.71%-60.71%71.57%
Enterprise Value
54.33333.23932.242,3531,1832,944
Last Close Price
5.596.6921.1053.5027.7070.50
Forward PE
-7.8717.5823.2617.8722.03
PEG Ratio
-1.031.031.031.031.03
PS Ratio
0.293.469.8820.6810.0624.39
PB Ratio
2.4921.7814.6831.7715.7834.78
P/TBV Ratio
2.482.161.453.111.593.41
P/FCF Ratio
13.2054.67-189.68-43292.10
P/OCF Ratio
8.1844.45645.81165.50989.282298.39
EV/Sales Ratio
0.643.859.9020.9610.4424.76
EV/EBITDA Ratio
6.95-985.46264.601843.36303.95
EV/EBIT Ratio
26.62--1242.26-1425.14
EV/FCF Ratio
28.4460.91-192.23-43945.30
Debt / Equity Ratio
4.243.110.100.490.670.62
Debt / EBITDA Ratio
7.67-45.814.6584.495.88
Debt / FCF Ratio
22.297.81-3.38-850.15
Net Debt / Equity Ratio
3.532.490.620.510.690.59
Net Debt / EBITDA Ratio
6.39-0.8041.474.1777.475.07
Net Debt / FCF Ratio
18.576.24-32.583.03-113.55733.42
Asset Turnover
1.080.840.710.790.740.75
Inventory Turnover
1.651.661.641.811.942.06
Quick Ratio
0.911.120.350.770.911.17
Current Ratio
1.992.200.821.852.202.43
Return on Equity (ROE)
-170.69%-169.98%-26.18%-10.83%-15.12%-3.12%
Return on Assets (ROA)
-0.11%-46.51%-4.91%1.50%-4.64%1.38%
Return on Invested Capital (ROIC)
-0.13%-51.82%-5.28%1.62%-5.03%1.51%
Return on Capital Employed (ROCE)
-0.15%-74.86%-6.81%1.63%-5.35%1.52%
FCF Yield
7.58%1.83%-0.53%-0.00%
Buyback Yield / Dilution
-1.92%-1.96%-2.64%-2.43%-2.65%-4.41%
Total Shareholder Return
-1.92%-1.96%-2.64%-2.43%-2.65%-4.41%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q